For the quarter ending 2025-09-30, IVF has $18,832,198 in assets. $12,983,476 in debts.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 355,891 | 549,181 | ||
| Current assets held for sale | - | 0 | ||
| Accounts receivable | 274,200 | 242,255 | ||
| Inventory | 191,762 | 212,611 | ||
| Prepaid expenses and other current assets | 314,952 | 395,306 | ||
| Total current assets | 1,136,805 | 1,399,353 | ||
| Property and equipment, net | 405,417 | 428,746 | ||
| Lease right of use | 2,096,739 | 2,160,380 | ||
| Intangible assets, net | 1,430,495 | 1,535,845 | ||
| Goodwill | 5,878,986 | 5,878,986 | ||
| Equity investments | 613,771 | 645,944 | ||
| Investment in naya | 2,466,810 | 2,466,810 | ||
| Noncurrent assets held for sale | - | 0 | ||
| Note receivable | 4,803,175 | 4,803,175 | ||
| Total assets | 18,832,198 | 19,319,239 | ||
| Notes payable related parties, net-Related Party | - | 880,000 | ||
| Current liabilities held for sale | 0 | 0 | ||
| Accounts payable and accrued liabilities | 2,391,222 | 2,226,600 | ||
| Accrued compensation | 342,957 | 365,694 | ||
| Convertible notes payable-Nonrelated Party | 149,293 | - | ||
| Convertible notes payable-Related Party | 880,000 | - | ||
| Deferred revenue | 720,407 | 834,850 | ||
| Convertible notes payable current portion, net | - | 2,888,947 | ||
| Additional payments for acquisition, current portion | 4,484,500 | 5,000,000 | ||
| Other current liabilities | 10,500 | 10,500 | ||
| Lease liability, current portion | 265,808 | 256,620 | ||
| Total current liabilities | 9,244,687 | 12,463,211 | ||
| Notes payable, net of current portion | 951,668 | 1,041,492 | ||
| Additional payments for acquisition, net of current portion | 800,000 | 1,125,000 | ||
| Lease liability, net of current portion | 1,987,121 | 2,058,063 | ||
| Total liabilities | 12,983,476 | 16,687,766 | ||
| Preferred stock value-Series COne Preferred Stock | 0 | 0 | ||
| Preferred stock value-Series CTwo Preferred Stock | 8,877,359 | 10,121,922 | ||
| Common stock, .0001 par value 50,000,000 shares authorized 5,423,801 and 124,345 issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 542 | 83 | ||
| Additional paid-in capital | 90,063,124 | 82,712,709 | ||
| Accumulated deficit | -93,092,303 | -90,203,241 | ||
| Total stockholders equity | 5,848,722 | 2,631,473 | ||
| Total liabilities, mezzanine equity, and stockholders equity | 18,832,198 | 19,319,239 | ||
INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. (IVF)